Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $165,548 | 98 | 81.5% |
| Travel and Lodging | $20,843 | 60 | 10.3% |
| Food and Beverage | $12,471 | 413 | 6.1% |
| Consulting Fee | $3,853 | 3 | 1.9% |
| Education | $342.63 | 18 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $132,811 | 205 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $22,493 | 36 | $0 (2024) |
| AKEBIA THERAPEUTICS INC | $16,312 | 36 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $15,756 | 60 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $6,030 | 31 | $0 (2024) |
| Keryx Biopharmaceuticals, Inc. | $5,333 | 8 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $507.75 | 28 | $0 (2024) |
| Horizon Therapeutics plc | $459.14 | 14 | $0 (2023) |
| Fresenius USA Marketing, Inc. | $419.34 | 22 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $408.93 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,603 | 82 | AstraZeneca Pharmaceuticals LP ($11,419) |
| 2023 | $17,577 | 82 | Bayer Healthcare Pharmaceuticals Inc. ($12,876) |
| 2022 | $15,445 | 68 | Bayer HealthCare Pharmaceuticals Inc. ($9,477) |
| 2021 | $16,861 | 60 | Amgen Inc. ($11,481) |
| 2020 | $14,425 | 61 | Amgen Inc. ($13,691) |
| 2019 | $47,319 | 88 | Amgen Inc. ($39,323) |
| 2018 | $56,388 | 100 | Amgen Inc. ($45,183) |
| 2017 | $22,439 | 51 | Amgen Inc. ($22,059) |
All Payment Transactions
592 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Nephrology | ||||||
| 12/11/2024 | CorMedix Inc. | DefenCath (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Catheter Lock Solution | ||||||
| 12/06/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $22.82 | General |
| 12/06/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $17.75 | General |
| Category: NEPHROLOGY | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/15/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/06/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Nephrology | ||||||
| 11/05/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/01/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $21.02 | General |
| 10/28/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Rare Disease | ||||||
| 10/24/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/23/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: NEPHROLOGY | ||||||
| 10/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Cardio-renal | ||||||
| 09/27/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/24/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/17/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: CRITICAL CARE | ||||||
| 08/28/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Inflammation | ||||||
| 08/26/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: NEPHROLOGY | ||||||
| 08/23/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $21.55 | General |
| 08/23/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $4.15 | General |
| 08/19/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $24.61 | General |
| Category: Nephrology | ||||||
| 08/19/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Nephrology | ||||||
| 08/13/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/01/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 2,818 | 6,409 | $598,240 | $232,836 |
| 2022 | 35 | 3,558 | 7,830 | $753,850 | $301,321 |
| 2021 | 32 | 3,620 | 7,694 | $852,976 | $374,224 |
| 2020 | 35 | 4,108 | 8,848 | $886,258 | $411,350 |
All Medicare Procedures & Services
133 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 62 | 358 | $186,160 | $98,116 | 52.7% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 45 | 98 | $50,960 | $22,401 | 44.0% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 18 | 88 | $45,760 | $20,326 | 44.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 203 | 292 | $61,793 | $15,974 | 25.9% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 183 | 297 | $36,780 | $11,980 | 32.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 44 | 114 | $32,454 | $10,168 | 31.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 58 | 77 | $15,850 | $6,898 | 43.5% |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2023 | 26 | 941 | $26,339 | $5,797 | 22.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 218 | 461 | $14,604 | $4,767 | 32.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 223 | 477 | $7,155 | $4,007 | 56.0% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 51 | 74 | $16,204 | $3,913 | 24.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 217 | 436 | $21,800 | $3,305 | 15.2% |
| 83735 | Magnesium level | Office | 2023 | 215 | 415 | $8,342 | $2,722 | 32.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 25 | 25 | $6,789 | $2,462 | 36.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 30 | 37 | $5,285 | $2,224 | 42.1% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 213 | 413 | $12,390 | $2,094 | 16.9% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 22 | 32 | $8,186 | $2,067 | 25.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 15 | $5,990 | $1,978 | 33.0% |
| 84100 | Phosphate level | Office | 2023 | 214 | 419 | $5,958 | $1,944 | 32.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,844 | $1,507 | 39.2% |
| 84156 | Total protein level, urine | Office | 2023 | 213 | 413 | $4,547 | $1,484 | 32.6% |
| 80197 | Tacrolimus level | Office | 2023 | 31 | 104 | $4,284 | $1,400 | 32.7% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 214 | 414 | $3,937 | $1,285 | 32.6% |
| 82306 | Vitamin d-3 level | Office | 2023 | 30 | 31 | $2,753 | $878.02 | 31.9% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 36 | 51 | $2,085 | $681.36 | 32.7% |
About Dr. William Kendrick, M.D
Dr. William Kendrick, M.D is a Nephrology healthcare provider based in Greenville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1407858632.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Kendrick, M.D has received a total of $203,057 in payments from pharmaceutical and medical device companies, with $12,603 received in 2024. These payments were reported across 592 transactions from 42 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($165,548).
As a Medicare-enrolled provider, Kendrick has provided services to 14,104 Medicare beneficiaries, totaling 30,781 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 133 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Greenville, NC
- Active Since 06/01/2005
- Last Updated 12/27/2011
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1407858632
Products in Payments
- Parsabiv (Biological) $100,668
- Parsabiv (Drug) $25,948
- Kerendia (Drug) $22,493
- FARXIGA (Drug) $15,121
- Auryxia (Drug) $14,309
- AURYXIA (Drug) $7,290
- Sensipar (Drug) $5,898
- Rayaldee (Drug) $5,763
- KRYSTEXXA (Biological) $623.42
- Veltassa (Drug) $471.38
- LOKELMA (Drug) $455.63
- Velphoro (Drug) $405.16
- JYNARQUE (Drug) $330.34
- RAYALDEE (Drug) $253.02
- LUPKYNIS (Drug) $197.51
- ACTHAR (Biological) $187.12
- SAMSCA (Drug) $177.41
- ULTOMIRIS (Biological) $173.26
- TARPEYO (Drug) $151.93
- VAPRISOL DEXTROSE IN PLASTIC CONTAINER (Drug) $143.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Greenville
Dr. Barry Gorlitsky, Md, MD
Nephrology — Payments: $175,603
Blake Shusterman, Md, MD
Nephrology — Payments: $66,159
Richard Blair, M.d, M.D
Nephrology — Payments: $13,340
Anthony Provenzano
Nephrology — Payments: $10,873
Dr. Amita Patel, M.d, M.D
Nephrology — Payments: $9,091
Dr. Wilson Parry, Md, MD
Nephrology — Payments: $7,778